November 22, 2022 – Therapy with DNA repair inhibitors in early phase clinical trials

To test if the resistance-conferring mutations directly hinder arylomycin C16 binding SPase that does not have the N-terminal membrane helices, but nonetheless affiliates with micelles (Kuo et al

November 22, 2022 climat2050

To test if the resistance-conferring mutations directly hinder arylomycin C16 binding SPase that does not have the N-terminal membrane helices, but nonetheless affiliates with micelles

Day: November 22, 2022

﻿To test if the resistance-conferring mutations directly hinder arylomycin C16 binding SPase that does not have the N-terminal membrane helices, but nonetheless affiliates with micelles (Kuo et al

To test if the resistance-conferring mutations directly hinder arylomycin C16 binding SPase that does not have the N-terminal membrane helices, but nonetheless affiliates with micelles (Kuo et al